Search Clinical Trials
598,193 trials
ID
Status
Phase
Title
Sponsor
NCT07762079
A Study of Engagement in the "Résonance(s)" Musical and Experiential Immersion Program Among Patients With Mental Disorders - IRISFederation Regionale de Recherche en Psychiatrie et Sante Mentale OccitanieNot Yet RecruitingNot Applicable
NCT07762079Not Yet Recruiting
Not Applicable
A Study of Engagement in the "Résonance(s)" Musical and Experiential Immersion P...Federation Regionale de R...
NCT07763067
Acceptability and Outcomes of an Online Parent-Mediated Intervention for Young Autistic ChildrenHerguner Therapy Private ClinicCompletedNot Applicable
NCT07763067Completed
Not Applicable
Acceptability and Outcomes of an Online Parent-Mediated Intervention for Young A...Herguner Therapy Private...
NCT07763496
Relacorilant and Nab-Paclitaxel in Recurrent or Metastatic Cervical CancerARCAGY/ GINECO GROUPNot Yet RecruitingPhase 2
NCT07763496Not Yet Recruiting
Phase 2
Relacorilant and Nab-Paclitaxel in Recurrent or Metastatic Cervical CancerARCAGY/ GINECO GROUP
NCT07764107
Photobiomodulation for Reducing Sedative-Hypnotic Use:Clinical Trial of a Light-Therapy DeviceNational Health Research Institutes, TaiwanNot Yet RecruitingNot Applicable
NCT07764107Not Yet Recruiting
Not Applicable
Photobiomodulation for Reducing Sedative-Hypnotic Use:Clinical Trial of a Light-...National Health Research...
NCT07764081
Progression, Management, and Clinical Outcomes of Coronary Artery AneurysmsNanjing First Hospital, Nanjing Medical UniversityRecruiting
NCT07764081Recruiting
—
Progression, Management, and Clinical Outcomes of Coronary Artery AneurysmsNanjing First Hospital, N...
NCT07762638
Post Trial Access to Lucerastat for Patients With Fabry Disease Who Participated in Study ID-069A302Idorsia Pharmaceuticals Ltd.Unknown
NCT07762638Unknown
—
Post Trial Access to Lucerastat for Patients With Fabry Disease Who Participated...Idorsia Pharmaceuticals L...
NCT07762703
Combination Immunotherapy Treatment for Locally Advanced Unresectable or Metastatic, PD-L1 Negative (CPS<10), gBRCA Negative, Triple Negative Breast Cancer Including BreakVax ImmunoTreatment (Designed and Manufactured Per Patient), Chemotherapy and Anti PD-1 TherapyBreakBio CorpNot Yet RecruitingPhase 1
NCT07762703Not Yet Recruiting
Phase 1
Combination Immunotherapy Treatment for Locally Advanced Unresectable or Metasta...BreakBio Corp
NCT07764003
A Study of Efficacy and Safety of TLL-018 in CSU Participants With Inadequate Response to 2nd-generation H1-AHsHangzhou Highlightll Pharmaceutical Co., LtdNot Yet RecruitingPhase 2
NCT07764003Not Yet Recruiting
Phase 2
A Study of Efficacy and Safety of TLL-018 in CSU Participants With Inadequate Re...Hangzhou Highlightll Phar...
NCT07763873
A Study Examining Acceptability of Auditory Implant Fitting Software TechnologiesCochlearNot Yet RecruitingNot Applicable
NCT07763873Not Yet Recruiting
Not Applicable
A Study Examining Acceptability of Auditory Implant Fitting Software Technologie...Cochlear
NCT07764172
Sarcopenia in Acute Ischemic StrokeUniversity Clinical Hospital na V.V.Vinogradov (branch of RUDN university na Patrice Lumumba)Recruiting
NCT07764250
Comparative Evaluation of Immediate vs Progressive Standing Dual Task Training in Elderly With Mild and Moderate Cognitive ImpairmentShifa Tameer-e-Millat UniversityRecruitingNot Applicable
NCT07764250Recruiting
Not Applicable
Comparative Evaluation of Immediate vs Progressive Standing Dual Task Training i...Shifa Tameer-e-Millat Uni...
NCT07762794
Multicenter Study to Evaluate the Safety and Efficacy of SYMVESS™ in a Real World Setting in Patients With Extremity Arterial Injury Requiring Urgent RepairHumacyte, Inc.Not Yet RecruitingPhase 4
NCT07762794Not Yet Recruiting
Phase 4
Multicenter Study to Evaluate the Safety and Efficacy of SYMVESS™ in a Real Worl...Humacyte, Inc.
NCT07762053
Clinical Investigation of Eye C Better's Photobionic Intraocular Pressure Biomonitor TonometerEyeCBetter CorporationNot Yet RecruitingNot Applicable
NCT07762053Not Yet Recruiting
Not Applicable
Clinical Investigation of Eye C Better's Photobionic Intraocular Pressure Biomon...EyeCBetter Corporation
NCT07763821
Clinical Utility of Serum Ribonuclease 1(RNASE1) as a Biomarker of Lupus Nephritis.Assiut UniversityNot Yet Recruiting
NCT07763821Not Yet Recruiting
—
Clinical Utility of Serum Ribonuclease 1(RNASE1) as a Biomarker of Lupus Nephrit...Assiut University
NCT07763860
Therapeutic Effects of Music on Procedural OutcomesBahaa Bou DarghamRecruitingNot Applicable
NCT07763860Recruiting
Not Applicable
Therapeutic Effects of Music on Procedural OutcomesBahaa Bou Dargham
NCT07763535
Is BMI Outdated in TKA Patient Selection? Assessment of the Impact of Pre-tubercular Subcutaneous Tissue Thickness and the Risk of Postoperative Infection Following Total Knee ArthroplastyEast Lancashire Hospitals NHS TrustNot Yet Recruiting
NCT07763535Not Yet Recruiting
—
Is BMI Outdated in TKA Patient Selection? Assessment of the Impact of Pre-tuberc...East Lancashire Hospitals...
NCT07763171
Paclitaxel, Ramucirumab and Tislelizumab Switch Maintenance in Advanced HER2-negative and PD-L1 TAP Score of 5 or More Advanced Gastroesophageal AdenocarcinomaGruppo Oncologico del Nord-OvestNot Yet RecruitingPhase 3
NCT07763171Not Yet Recruiting
Phase 3
Paclitaxel, Ramucirumab and Tislelizumab Switch Maintenance in Advanced HER2-neg...Gruppo Oncologico del Nor...
NCT07762989
Donor Ankle Sensorimotor Recovery After ACL Reconstruction With a Peroneus Longus Tendon AutograftGazi UniversityNot Yet Recruiting
NCT07762989Not Yet Recruiting
—
Donor Ankle Sensorimotor Recovery After ACL Reconstruction With a Peroneus Longu...Gazi University
NCT07763587
Analysis of Multimodal Psychosomatic Comorbidity Burden in Breast Cancer and Benefit Evaluation of Acupuncture Collaborative Management RegimenFirst Teaching Hospital of Tianjin University of Traditional Chinese MedicineNot Yet RecruitingNot Applicable
NCT07763587Not Yet Recruiting
Not Applicable
Analysis of Multimodal Psychosomatic Comorbidity Burden in Breast Cancer and Ben...First Teaching Hospital o...
Result Breakdown
Not yet recruiting13 (65%)
Recruiting5 (25%)
Completed1 (5%)
Unknown1 (5%)
not_applicable8 (40%)
Not Specified7 (35%)
Phase 22 (10%)
Phase 11 (5%)
Phase 41 (5%)
Phase 31 (5%)